Document is current
Any future updates will be listed below
-
Authors
Bashorum, Lisa
McCaughey, Gerard
Evans, Owen
Humphries, Ashley C.
Perry, Richard
MacCulloch, Alasdair https://orcid.org/0000-0001-9904-9063
-
Funding
Funding for this research was provided by:
Amicus Therapeutics
- License Information
-
More Information
Article History
Received: 15 December 2021
Accepted: 30 June 2022
First Online: 15 July 2022
Declarations
:
: This study was qualified for exemption from the need for IRB review by the Ethical and Independent Review Services. In line with IRB and BHBIA guidance, all respondents provided informed consent before participating in the study.
: Not applicable.
: LB, GM and AM are employees of Amicus Therapeutics who manufacture Galafold™. OE, ACH and RP are employees of Adelphi Values PROVE who were contracted by Amicus Therapeutics to carry out the study and to support with medical writing.
